Tag: Metabolic modulator

According to the European Medicines Agency (EMA), headache is one of the common side effects associated with the cardiac medication trimetazidine, affecting up to 1 in 10 people. While generally considered mild, any new or persistent headache experienced while taking this drug should be discussed with a healthcare provider.

While commonly prescribed in Europe and other parts of the world to treat angina, trimetazidine is not approved for clinical use by the US Food and Drug Administration (FDA). This critical distinction means the medication is unavailable for prescription or sale as a pharmaceutical product within the United States.

Originally marketed in France, trimetazidine is a metabolic agent that shifts cardiac energy metabolism to improve efficiency during reduced blood flow. So, **what is trimetazidine used for**? It is primarily indicated as an add-on therapy for patients with stable angina pectoris whose symptoms are not adequately controlled by or who are intolerant to other medications.

In one study of patients with stable angina, adding Trimetazidine to their treatment regimen led to a nearly sixfold increase in the number of individuals becoming angina-free over six months. So, **what is Trizid SR 60 mg used for?** It is an anti-anginal medication for heart-related chest pain.